Correlation Between Cingulate Warrants and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Fennec Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Fennec Pharmaceuticals
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cingulate and Fennec is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Fennec Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 40.87 times more return on investment than Fennec Pharmaceuticals. However, Cingulate Warrants is 40.87 times more volatile than Fennec Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 6.00 in Cingulate Warrants on August 24, 2024 and sell it today you would lose (2.23) from holding Cingulate Warrants or give up 37.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 75.2% |
| Values | Daily Returns |
Cingulate Warrants vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Cingulate Warrants |
| Fennec Pharmaceuticals |
Cingulate Warrants and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Fennec Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Cingulate Warrants vs. Lyra Therapeutics | Cingulate Warrants vs. Hookipa Pharma | Cingulate Warrants vs. SAB Biotherapeutics | Cingulate Warrants vs. Cadrenal Therapeutics, Common |
| Fennec Pharmaceuticals vs. Lyra Therapeutics | Fennec Pharmaceuticals vs. Hookipa Pharma | Fennec Pharmaceuticals vs. Cingulate Warrants | Fennec Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |